Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
51
Cognitive and behavioral approach to suicide prevention tailored for individuals with psychosis
Standard psychiatric and behavioral services provided at community mental health (e.g., case management, medication management)
University of Michigan
Ann Arbor, Michigan, United States
Calgary Depression Rating Scale (CDRS)
A scale to measure depression, higher scores indicate greater depression (range of 0-27)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Positive and Negative Syndrome Scale (PANSS)
A scale to measure psychosis symptoms, higher scores indicate greater psychosis (range of 30-210)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Columbia Suicide Severity Rating Scale (C-SSRS)
A scale to measure suicide thoughts and behavior, higher scores indicate greater suicide thoughts and behavior (range of 0-5)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Beck Hopelessness Scale
A scale to measure hopelessness, higher scores indicate greater hopelessness (range of 0-20)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
Defeat Scale (D Scale)
A scale to measure defeat, higher scores indicate greater defeat (range of 0-64)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
The Entrapment Scale
A scale to measure entrapment, higher scores indicate greater entrapment (range of 0-64)
Time frame: 4 time points (baseline, mid-treatment (1 month), post-treatment (3 months), and follow-up (5 months).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.